Jim O’Neill, an associate of Silicon Valley venture capital investor and entrepreneur Peter Thiel, is being considered by President-elect Donald Trump’s transition team to head the FDA, people familiar with the matter said. O’Neill was an associate deputy secretary at HHS in the George W. Bush administration.